Katsuhito Hashidzume
President bij HUMAN METABOLOME TECHNOLOGIES, INC.
Vermogen: 30 485 $ op 31-03-2024
Profiel
Katsuhito Hashidzume currently works at Human Metabolome Technologies, Inc., as President & Representative Director from 2019, HMT Biomedical KK, as President & Representative Director from 2018, and Mediome KK, as Non-Executive Director from 2018.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2023 | 7 044 ( 0.12% ) | 30 485 $ | 31-03-2024 |
Actieve functies van Katsuhito Hashidzume
| Bedrijven | Functie | Begin |
|---|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | President | 21-09-2019 |
HMT Biomedical KK
 HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | President | 01-12-2018 |
| Mediome KK | Director/Board Member | 01-12-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HUMAN METABOLOME TECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
HMT Biomedical KK
HMT Biomedical KK Pharmaceuticals: MajorHealth Technology Part of Human Metabolome Technologies, Inc., HMT Biomedical KK is a Japanese company that operates in the metabolomics business. The company's description is in Japanese, but it can be translated to mean that it is a domestic information site for HMT, which is a company that develops metabolomics technology. | Health Technology |
| Mediome KK |
